You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Medullary Carcinoma of Colon

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Recruiting
  • Thyroid Cancer, Nonmedullary
  • Colon Carcinoma
  • no intervention will take place
  • Nijmegen, Gelderland, Netherlands
    RadboudUMC
Sep 21, 2022

Medullary Colonic Carcinoma

Completed
  • Medullary Carcinoma of Colon
  • +2 more
    • Limoges, France
      Service de Chirurgie Digestive et Endocrinienne du CHU de Limoge
    Jan 7, 2022

    Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

    Active, not recruiting
    • Breast Cancer
    • +11 more
    • radionuclide imaging
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Oct 20, 2022

    Medullary Thyroid Carcinoma, Nodular Goiter Trial in Pilar (Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin

    Completed
    • Medullary Thyroid Carcinoma
    • Nodular Goiter
    • Fine Needle Aspiration Cytology (FNAC) procedure+calcitonin measurement
    • Pilar, Buenos Aires, Argentina
      Hospital Universitario Austral
    Oct 5, 2023

    Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

    Not yet recruiting
    • Non-Medullary Thyroid Carcinoma
    • Digoxin tablet
    • (no location specified)
    Aug 20, 2022

    Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

    Not yet recruiting
    • Bronchial and Thymic Neuroendocrine Tumour
    • +3 more
    • Lu-177 DOTATATE (Lutathera®)
    • (no location specified)
    Nov 1, 2023

    A Detailed Look At What Patients Experience In Medullary Thyroid

    Not yet recruiting
    • Medullary Thyroid Cancer
      • San Francisco, California
        Power Life Sciences
      Oct 6, 2023

      Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)

      Enrolling by invitation
      • Diabetes
      • +3 more
      • No treatment given
      • Morgantown, West Virginia
        United BioSource, LLC
      Oct 4, 2022

      Kidney Medullary Carcinoma, Loss of INI 1 Protein Expression, Stage III Renal Cell Cancer AJCC v8 Trial in Houston (Ipilimumab,

      Active, not recruiting
      • Kidney Medullary Carcinoma
      • +3 more
      • Ipilimumab
      • Nivolumab
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 22, 2022

      Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • +3 more
      • Groningen, Netherlands
        University Medical Centre Groningen
      Sep 8, 2022

      Carcinomas, Renal Medullary Carcinoma Trial in Houston (Nivolumab, Relatlimab)

      Not yet recruiting
      • Carcinomas
      • Renal Medullary Carcinoma
      • Houston, Texas
        MD Anderson Cancer Center
      Apr 20, 2022

      Medullary Thyroid Carcinoma Trial in Angers, Nantes, Saint-Herblain (• TF2 and 68 Ga-IMP-288)

      Completed
      • Medullary Thyroid Carcinoma
      • • TF2 and 68 Ga-IMP-288
      • Angers, France
      • +2 more
      Jul 22, 2022

      Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

      Recruiting
      • Medullary Thyroid Cancer
      • Anlotinib Hydrochloride Capsule
      • Hefei, Anhui, China
      • +18 more
      Apr 14, 2023

      Textbook Outcome in Colon Carcinoma

      Completed
      • Outcome Assessment
      • Cancer of Colon
      • Colon oncological resection
      • Alicante, Spain
        Hospital General Universitario Dr. Balmis
      Jan 5, 2023

      RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

      Not yet recruiting
      • RET-altered Non Small Cell Lung Cancer
      • +3 more
      • Chang chun, Jilin, China
        Jinlin Province Cancer Hosipital
      Dec 21, 2022

      Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

      Not yet recruiting
      • Medullary Thyroid Cancer
      • Cordoba, Spain
      • +1 more
      Jan 11, 2023

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

      Recruiting
      • Metastatic Medullary Thyroid Cancer
      • single dose of CART-GFRa4 cells
      • +2 more
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Sep 16, 2022

      Children and Adults With Medullary Thyroid Cancer

      Recruiting
      • Medullary Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 7, 2022

        Surgical Management of Advanced Thyroid Cancer

        Recruiting
        • Thyroid Carcinoma
        • +6 more
        • Thyroidectomy with or without lymphadenectomy or multivisceral resection
        • Rome, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 31, 2023

        NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

        Recruiting
        • Non-Small Cell Lung Cancer
        • +3 more
        • Scottsdale, Arizona
        • +84 more
        Oct 10, 2022

        Medullary Thyroid Carcinoma Trial in China (HA121-28 tablets)

        Recruiting
        • Medullary Thyroid Carcinoma
        • HA121-28 tablets
        • Beijing, Beijing, China
        • +12 more
        Feb 7, 2022

        RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

        Active, not recruiting
        • RET-altered Non Small Cell Lung Cancer
        • +39 more
        • pralsetinib (BLU-667)
        • Phoenix, Arizona
        • +65 more
        Nov 10, 2022

        Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

        Recruiting
        • Malignant Thyroid Gland Neoplasm
        • +6 more
        • Quality-of-Life Assessment
        • +3 more
        • Ann Arbor, Michigan
        • +1 more
        Jan 24, 2023

        DOTATOC PET/CT for Imaging NET Patients

        Recruiting
        • Neuroendocrine Tumors
        • +15 more
        • 68Ga-DOTATOC PET/CT
        • 18F-FDG PET/CT
        • Vancouver, British Columbia, Canada
          BC Cancer
        Nov 2, 2022